Gilmore O Neill
Tracked across 1 events · 7 articles · First seen Sep 08, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Editas Medicine, a U.S. gene editing company, announced on September 8, 2026, the appointment of Dan Ory, M.D., as Chief Medical Officer, effective immediately. Dr. Ory, a biotechnology executive with over 25 years of experience…
Impact: Gilmore O Neill is the President and CEO of Editas Medicine, who commented on the appointment. This event does not directly affect him.
Sep 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Gilmore O Neill live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard